Patents for C40B 30 - Methods of screening libraries (11,320) |
---|
06/07/2012 | US20120142547 Polypeptide immobilization |
06/07/2012 | US20120142546 Hypomethylated genes in cancer |
06/07/2012 | US20120142545 Solid phase and catalyzed enabled automated isotope dilution and speciated isotope dilution mass spectrometry |
06/07/2012 | US20120142544 Diagnostic transcriptomic biomarkers in inflammatory cardiomyopathies |
06/07/2012 | US20120142543 Methods to assess treatment outcomes in Reward Deficiency Syndrome (RDS) behaviors utilizing expression profiling |
06/07/2012 | US20120142542 Metabolite Biomarkers for the Detection of Esophageal Cancer Using NMR |
06/07/2012 | US20120142541 Structured Peptide Processing |
06/07/2012 | US20120141604 Novel compositions and methods for the identification, assessment, prevention and therapy of human cancers |
06/07/2012 | US20120141603 Methods and compositions for lung cancer prognosis |
06/07/2012 | US20120141539 Methods for modulating toll-like receptor mediated activation of cells of the innate system by modulating xbp-1 activity |
06/07/2012 | US20120141537 Enhancing t cell activation using altered mhc-peptide ligands |
06/07/2012 | US20120141505 Cd19-ligand and use |
06/07/2012 | US20120141502 Antibodies specific to e6 proteins of hpv and use thereof |
06/07/2012 | US20120141463 Method Of Identifying Membrane Ig Specific Antibodies And Use Thereof For Targeting Immunoglobulin-Producing Precursor Cells |
06/07/2012 | US20120141450 Risk markers for cardiovascular disease |
06/07/2012 | CA2819345A1 Methods to assess treatment outcomes in reward deficiency syndrome (rds) behaviors utilizing expression profiling |
06/06/2012 | EP2459751A1 Method for determining the presence and concentration of analytes using a nucleic acid ligand and rare earth element |
05/31/2012 | US20120135950 Antiviral treatment of lymphoma and cancer |
05/31/2012 | US20120135888 Method for predicting the response of locally advanced rectal cancer to chemoradiotherapy |
05/31/2012 | US20120135887 Cell handling, electroporation and electrofusion in microfluidic systems |
05/31/2012 | US20120135886 Method for detection of, or the risk of, bladder cancer |
05/31/2012 | US20120135885 Methods and Kits Using Extended Rhodamine Dyes |
05/31/2012 | US20120135884 Compositions and methods for diagnosing and treating macular degeneration |
05/31/2012 | US20120135883 Multivalent opsonophagocytic assay using bead array and imaging |
05/31/2012 | US20120135882 Methods for diagnosing chronic kidney disease and assessing the risk of disease progression |
05/31/2012 | US20120135881 Markers for detection of gastric cancer |
05/31/2012 | US20120135880 Crystal of Human Glycoprotein VI Collagen Binding Domain |
05/31/2012 | US20120135879 Method and Composition for Cancer Diagnosis and Treatment |
05/31/2012 | US20120135878 Generation of Neural Stem Cells from Human Trophoblast Stem Cells |
05/31/2012 | US20120135877 DNA Methylation Markers For Prostate Cancer Field Defect |
05/31/2012 | US20120135876 High-throughput assay methods and articles |
05/31/2012 | US20120135875 Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
05/31/2012 | US20120135874 Single molecule spectroscopy for analysis of cell-free nucleic acid biomarkers |
05/31/2012 | US20120135873 Genome determination assay |
05/31/2012 | US20120135872 Methods of fetal abnormality detection |
05/31/2012 | US20120135000 Methods and compositions for treating ocular disorders |
05/31/2012 | US20120134995 Method for predicting the therapeutic responseiveness of a patient to a medical treatment with an egfr inhibitor |
05/31/2012 | CA2818890A1 Method and system for prognosis and treatment of diseases using portfolio of genes |
05/30/2012 | CN1754225B Playback device, recording method and playback method |
05/30/2012 | CN101443022B Use of a growth-stimulating protein |
05/29/2012 | US8188011 Optimization of ligand affinity for RNA targets using mass spectrometry |
05/29/2012 | US8187828 Use of PAK inhibitor for the treatment of a joint disease |
05/24/2012 | WO2012068372A1 Method of and system for printing in-well calibration features |
05/24/2012 | WO2012068170A2 Generation of neural stem cells from human trophoblast stem cells |
05/24/2012 | US20120129888 Libraries of n-(2-oxo-1-phenylpiperidin-3-yl)sulfonamides for drug discovery |
05/24/2012 | US20120129880 Method for determining sensitivity to irinotecan and use thereof |
05/24/2012 | US20120129835 Schizophrenia methods and compositions |
05/24/2012 | US20120129727 Efficient and effective supplement screening for the development of chemically defined media in cell culture |
05/24/2012 | US20120129726 Subcellular in vivo time-lapse imaging and surgery of c. elegans in standard multiwell plates |
05/24/2012 | US20120129725 Nucleic acid nano-biosensors |
05/24/2012 | US20120129724 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells |
05/24/2012 | US20120129723 System and method for carrying out multiple binding reactions in an array format |
05/24/2012 | US20120129722 Method for screening new drug candidate inhibiting target protein-protein interaction for development of first-in-class drug |
05/24/2012 | US20120129721 Urinary gm2 activator protein as a marker of acute renal failure or the risk of developing acute renal failure |
05/24/2012 | US20120129720 Aptamer that recognizes peptide |
05/24/2012 | US20120129719 Mechanically induced trapping of molecular interactions |
05/24/2012 | US20120129718 Qualitative/Quantitative Detection of Fungal Species |
05/24/2012 | US20120129717 Collection and Methods For Its Use |
05/24/2012 | US20120129716 Use of microfluidic systems in the detection of target analytes using microsphere arrays |
05/24/2012 | US20120129715 Gb1 peptidic libraries and methods of screening the same |
05/24/2012 | US20120129714 Quantitative multiplexed identification of nucleic acid targets |
05/24/2012 | US20120129713 Substrates For Isolating, Reacting And Microscopically Analyzing Materials |
05/24/2012 | US20120129712 Antibodies directed to tra antigens, and methods of production, screening and analysis of said antibodies, as well as methods of analysis of stem cells and cancer cell |
05/24/2012 | US20120129711 Biomarkers for the prognosis and high-grade glioma clinical outcome |
05/24/2012 | US20120129710 Methods for producing members of specific binding pairs |
05/24/2012 | US20120129709 Sensor for detection of nucleic acid |
05/24/2012 | US20120129708 Compositions and methods for predicting cardiovascular events |
05/24/2012 | US20120129707 Glycopeptide-Functionalized Nanoparticles Arrays for Capturing and Detecting Biomolecules |
05/24/2012 | US20120129706 Method of Assessing Soil Quality and Health |
05/24/2012 | US20120129705 Diagnostic markers for determining the predisposition to the development of cervical cancer and oligonucleotides used for the determination |
05/24/2012 | US20120129167 Truncated cd20 protein, deltacd20 |
05/24/2012 | US20120128702 Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer |
05/24/2012 | US20120128651 Acute lymphoblastic leukemia (all) biomarkers |
05/24/2012 | US20120128642 Potency markers |
05/24/2012 | CA2818483A1 Method of and system for printing in-well calibration features |
05/24/2012 | CA2818234A1 Generation of neural stem cells from human trophoblast stem cells |
05/24/2012 | CA2759290A1 Qualitative/quantitative detection of fungal species |
05/23/2012 | EP2453908A2 Bifunctional stapled polypeptides and uses thereof |
05/18/2012 | WO2012027546A3 Poised th17 cells, methods of isolation, and methods of use |
05/18/2012 | WO2012027389A3 Mechanically-activated cation channels |
05/18/2012 | WO2012009554A3 Methods and systems for in vivo clinical data measurement of analytes |
05/17/2012 | US20120122959 Targeting MicroRNAs for Metabolic Disorders |
05/17/2012 | US20120122950 Libraries of 1-(sulfonyl)-n-phenylpyrrolidine-2-carboxamides for drug discovery |
05/17/2012 | US20120122770 Cell Cycle Arrest and Apoptosis |
05/17/2012 | US20120122731 Screening molecular libraries using microfluidic devices |
05/17/2012 | US20120122730 Methods for Quantitative Analyses of Kinase Inhibitor Selectivity Using Small Size Panels |
05/17/2012 | US20120122729 Methods and Tests for Screening Bacterial Biofilms |
05/17/2012 | US20120122728 Method Of Screening Drugs For Reversal Of Amyloid Beta Neurotoxicity |
05/17/2012 | US20120122727 In vitro method for predicting whether a compound is genotoxic in vivo |
05/17/2012 | US20120122726 Markers for endometrial cancer |
05/17/2012 | US20120122725 Method of determining risk of a neuropsychiatric disorder |
05/17/2012 | US20120122724 Agents and Methods Related to Reducing Resistance to Apoptosis-Inducing Death Receptor Agonists |
05/17/2012 | US20120122723 Methods of detecting autoantibodies for diagnosing and characterizing disorders |
05/17/2012 | US20120122722 Expression of MBNL2 and Other Genes Associated with Bladder Cancer Progression |
05/17/2012 | US20120122721 Method for nucleic acid detection using voltage enhancement |
05/17/2012 | US20120122720 Means and methods for recognizing the development of cardiovascular disease in an individual |
05/17/2012 | US20120122719 Methods for PCR and HLA typing using unpurified samples |
05/17/2012 | US20120122718 BRM Expression and Related Diagnostics |
05/17/2012 | US20120122717 Composition and multiplex assays for measuring biological mediators of physiological health |
05/17/2012 | US20120122716 Cell line derived from the epithelial lining of the human endolymphatic sac in the inner ear |